Medicare utilization — DR. PHILIP SIMKOVITZ (MD)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| J0517 | Injection, benralizumab, 1 mg | 2,100 | 13 | $0 | $277,738 |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 970 | 179 | $0 | $64,132 |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 800 | 449 | $0 | $58,397 |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 369 | 79 | $0 | $15,350 |
| 96372 | Injection of drug or substance under skin or into muscle | 348 | 23 | $0 | $4,197 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·